MedicationStatement

Readiness: In review.

Open MedicationStatement profile on Simplifier

Profile base: FHIR R4 MedicationStatement.

Design choices

The profile preserves medication use reported during dental care by someone with knowledge of that use. Its value is the report and its source, including uncertainty. It does not turn the report into an authoritative prescription or an observed administration.

Medicine details are recorded only to the precision supported by the report. Text remains useful when the medicine cannot be identified structurally; a more precise product or dose must not be invented.

Medication information retrieved or imported from SFM or PLL remains outside this local statement's scope. Preserving that boundary avoids relabelling external information with a local author, lifecycle or confidence it did not have.

Use in practice

If a patient says today that they took ibuprofen last week, the report date and the period of use describe different events. Preserve both meanings when known. The person supplying the information is also distinct from the software carrying it.

The report can inform a dental assessment, but it does not itself prove that a prescription exists, that a dose was administered under observation, or that the reported list is complete. Compare the records in Medication and allergy.

EHDS and later FHIR versions

The EHDS Medication use model distinguishes statement status from treatment status and also supports information derived from prescriptions, dispenses and administrations. The DigiDOT reported-use scope covers only part of that wider model. A future shared medication summary must preserve sources and address reconciliation separately.

FHIR R5 MedicationStatement substantially changes status semantics, changes medication to CodeableReference and renames context to encounter. Existing R4 statuses describing medication use must not simply be copied into the R5 statement-status field. See the shared assessment.